Agency officials said this week that they have received reports of problems after patients used versions of semaglutide, the active ingredient in the brand-name medications, which have been compounded, or mixed in pharmacies
It targets not just one, but several core mechanisms of aging simultaneously: telomere maintenance, epigenetic regulation, oxidative stress resilience, immune recalibration, and circadian rhythm restoration [1]
According to the UK Summary of Product Characteristics (SmPC), it's important to note that even after gallbladder removal, patients should be aware of potential acute biliary disease and pancreatitis risks
The most robust of these is the New Chemical Entity (NCE) exclusivity, granted to drug products containing an active moiety that has not been previously approved by the agency